Programme

Download as PDF

Thursday, 25 April 2024 Friday, 26 April 2024 Saturday, 27 April 2024

Filter session

Conference room

08:30 – 10:10

Session 1: Pathophysiology of hypertension in women Chairs: Michel Burnier, Renata Cifkova

100 min

08:30 - 08:50

Sex hormones and BP regulation Renata Cifkova

08:50 - 09:10

Salt and salt sensivity of BP in women Antoinette Pachère

09:10 - 09:30

Autonomic nerve activity in women Dagmara Hering

09:30 - 09:50

Endothelin and the RAAS in pre-eclampsia: what role? A.H. Jan Danser

09:50 - 10:10

Sex diffrences in gut microbiota composiotion Barbara Verhaar

10:30 – 12:10

Session 2: Update on hypertension risk factors in women Chairs: Anna Shalimova, Krzysztof Narkiewicz

100 min

10:30 - 10:50

Arterial fibromuscular dysplasia: why is it more frequent in women? Alexandre Persu

10:50 - 11:10

Polygenic risk scores for BP and hypertensive disorders of pregnancy Jouko Marko Nurkkala

11:10 - 11:30

Endometriosis and risk of hypertension Gabriella Masszi

11:30 - 11:50

Polycystic ovary syndrome: an unrecognized CV risk factor? Stamatina Iliodromiti

11:50 - 12:10

Sleep disturbances and risk of hypertension: are there specificites in women? Jacek Wolf

13:30 – 16:00

Session 3: Hypertension-mediated organ damages: are there gender differences? Gender differences in heart and vessels. Chairs: Sverre Erik Kjeldsen, Michel Burnier

150 min

13:30 - 13:55

Left ventricular hypertrophy and atrial fibrillation Eva Gerdts

13:55 - 14:20

Arterial structure and function Rosa Maria Bruno

14:20 - 14:45

BP variability Grzegorz Bilo

14:45 - 15:10

Validating BP-measuring devices: what about pregnancy (on-line) Tomas Lucca Bothe

15:10 - 15:35

Heart failure with preserved ejection fraction and AF Sverre Erik Kjeldsen

15:35 - 16:00

Assisted reproductive technologies and premature vasculr aging Théo Meister

16:20 – 18:20

Session 4: Hypertension-mediated organ damegaes: are there gender differences? Chairs: Edyta Szurowska, Marius Miglinas

120 min

16:20 - 16:40

Gender differences in renal microcirculation Grégoire Wuerzner

16:40 - 17:00

Gender, development and progression of CKD Marius Miglinas

17:00 - 17:20

Impaired ferility in women with CKD Marcin Adamczak

17:20 - 17:40

Coronary heart disease management: what about gender differences? Jūratė Barysienė

17:40 - 18:00

Sex differences in hypertension and hypertensive phenotypes: the HELIUS study Bert-Jan H. van den Born

18:00 - 18:20

Discussion

Conference room

08:30 – 11:05

Session 5: Diagnosis and management of hypertension: are there gender differences? Chairs: Jana Brguljan, Agnieszka Olszanecka, prof. UJ

155 min

08:30 - 08:50

Low percentage of women in clinical trials: what implications? Jana Brguljan

08:50 - 09:10

White coat hypertension: is the gemder difference real? Gianfranco Parati, Milan

09:10 - 09:30

Women perception of the risk of hypertension and CV diseases Anna Szyndler

09:30 - 09:50

Assisted reproductive therapies and risk of hypertansion Emrush Rexhaj

09:50 - 10:10

Lifestyle programs after menopasue: possible? Véronique Cornelissen

10:10 - 10:30

Monitoring women before, during and after pregnancy: the POPPY study Ian Wilkinson

10:30 - 10:50

Gender ascpects of resistant and malignant hypertension Andrzej Januszewicz

10:50 - 11:05

Discussion

11:20 – 12:40

Session 5: Diagnosis and management of hypertension in women Chairs: Reinhold Kreutz, Andrzej Januszewicz

80 min

11:20 - 11:40

New data on women and hypertansion: what impact on future guidelines? Reinhold Kreutz

11:40 - 12:00

Assosciation of BP with CV complications according to gender: is the difference real? Teemu Niiranen

12:00 - 12:20

RAS blockers in women with childbearing potential: how to handle? Massimo Volpe

12:20 - 12:40

Sex-differences in hypertension management: does it matter? Christian Delles

Download program as PDF